Compare Stocks

Aquila Resources Inc., together with its subsidiaries, engages in the acquisition, exploration, and development of mineral properties in the United States and Canada. The company primarily explores for zinc, gold, copper, lead, silver, and nickel deposits. Its flagship property is the 100% owned Back Forty project, a development stage volcanogenic massive sulfide deposit located in Menominee County, Michigan. Aquila Resources Inc. is headquartered in Toronto, Canada.

Aura Biosciences, Inc., a clinical-stage biotechnology company, develops precision immunotherapies to treat a range of solid tumors. The company's proprietary platform enables the targeting of a range of solid tumors using virus-like particles conjugated with drugs or loaded with nucleic acids to create virus-like drug conjugates. Its lead candidate is bel-sar, which is in late-stage clinical development for the treatment of patients with primary choroidal melanoma and other ocular oncology indications, as well as in early-stage clinical development in bladder cancer. The company also focuses on assessing the safety and efficacy of bel-sar in treating a range of other solid tumors, including bladder cancer as an alternative to bacillus calmetteguérin therapy. Aura Biosciences, Inc. was incorporated in 2009 and is headquartered in Boston, Massachusetts.

Empowerment & Inclusion Capital I Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 1999 and is based in New York, New York.